Skip to main content

Interim Results

View Interim Results


About Uniphar

Read More About Uniphar


Investor News

Read Latest Investor News

Uniphar Vision

Our vision is to improve patient access to pharmaco-medical products and treatments by developing connectivity between manufacturers and healthcare stakeholders.

Financial Highlights

Uniphar represents a strong combination of scale, growth and profitability. In 2018, the Group generated revenue of €1.55 billion, gross profit of €159.6 million and EBITDA of €46.3 million on a pro forma basis.

1. Unaudited pro forma financial information for the year ended 31 December 2018 for Uniphar plc, Sisk Healthcare and Durbin

Read Financial Information


Recent News